AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading ABBV News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.00%135.040.6%$889.69m
PFEPfizer Inc.
0.06%33.800.8%$741.13m
MRKMerck & Co., Inc.
-0.07%65.510.6%$621.25m
BMYBristol-Myers Squibb Company
0.00%55.911.4%$478.94m
ABBVAbbVie, Inc.
-0.55%72.002.1%$439.88m
LLYEli Lilly and Company
0.00%83.051.0%$302.49m
NVSNovartis AG Sponsored ADR
0.39%85.650.2%$170.12m
AZNAstraZeneca PLC Sponsored ADR
-0.03%34.561.3%$130.22m
GSKGlaxoSmithKline plc Sponsored ADR
-0.21%43.810.2%$119.91m
SNYSanofi Sponsored ADR
0.00%49.390.2%$91.25m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.05%43.500.1%$86.67m
LCILannett Company, Inc.
0.00%20.5038.7%$11.32m
SCMPSucampo Pharmaceuticals, Inc. Class A
0.00%10.4014.4%$4.62m
AKTXAkari Therapeutics Plc Sponsored ADR
0.00%5.012.2%$0.38m
EPIXESSA Pharma Inc
0.00%0.570.0%$0.05m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.,00DYYX-E